Healthcare provider profile · identity verified

Stephen Lawrence Young

Physician Assistant · ESCANABA, MI · NPI 1922558600

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	286	44
Gabapentin	Gabapentin	249	29
Atorvastatin Calcium	Atorvastatin Calcium	208	54
Omeprazole	Omeprazole	202	51
Lisinopril	Lisinopril	201	64
Rosuvastatin Calcium	Rosuvastatin Calcium	167	48
Amlodipine Besylate	Amlodipine Besylate	160	40
Jardiance	Empagliflozin	124	24
Levothyroxine Sodium	Levothyroxine Sodium	117	29
Montelukast Sodium	Montelukast Sodium	117	31
Ozempic	Semaglutide	115	17
Metoprolol Succinate	Metoprolol Succinate	114	30
Pregabalin	Pregabalin	110	16
Duloxetine Hcl	Duloxetine Hcl	109	31
Fluticasone Propionate	Fluticasone Propionate	103	34
Albuterol Sulfate Hfa	Albuterol Sulfate	102	40
Potassium Chloride	Potassium Chloride	102	23
Pantoprazole Sodium	Pantoprazole Sodium	92	27
Tamsulosin Hcl	Tamsulosin Hcl	90	27
Metformin Hcl	Metformin Hcl	84	18
Eliquis	Apixaban	82	19
Prednisone	Prednisone	79	40
Alprazolam	Alprazolam	77	20
Losartan Potassium	Losartan Potassium	74	21
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	74	14
Hydrochlorothiazide	Hydrochlorothiazide	73	22
Meloxicam	Meloxicam	72	25
Famotidine	Famotidine	70	18
Furosemide	Furosemide	66	24
Ipratropium Bromide	Ipratropium Bromide	63	29
Tramadol Hcl	Tramadol Hcl	61	18
Lorazepam	Lorazepam	60	17
Ondansetron Odt	Ondansetron	56	20
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	55	17
Metformin Hcl Er	Metformin Hcl	55	18
Ventolin Hfa	Albuterol Sulfate	54	16
Trazodone Hcl	Trazodone Hcl	49	13
Metoprolol Tartrate	Metoprolol Tartrate	46	17
Venlafaxine Hcl Er	Venlafaxine Hcl	45	suppressed
Simvastatin	Simvastatin	43	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	42	11
Ondansetron Hcl	Ondansetron Hcl	42	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	41	suppressed
Allopurinol	Allopurinol	39	11
Bupropion Xl	Bupropion Hcl	39	suppressed
Glipizide Er	Glipizide	38	13
Buspirone Hcl	Buspirone Hcl	37	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	37	30
Diclofenac Sodium	Diclofenac Sodium	36	19
Sertraline Hcl	Sertraline Hcl	36	13
Azelastine Hcl	Azelastine Hcl	34	15
Mounjaro	Tirzepatide	34	suppressed
Carvedilol	Carvedilol	33	13
Tizanidine Hcl	Tizanidine Hcl	33	11
Acetaminophen-Codeine	Acetaminophen With Codeine	32	suppressed
Alendronate Sodium	Alendronate Sodium	31	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	31	suppressed
Ibuprofen	Ibuprofen	31	16
Oxycodone Hcl	Oxycodone Hcl	31	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	30	suppressed
Baclofen	Baclofen	30	suppressed
Bumetanide	Bumetanide	30	suppressed
Mirtazapine	Mirtazapine	30	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	30	suppressed
Citalopram Hbr	Citalopram Hydrobromide	29	suppressed
Topiramate	Topiramate	29	suppressed
Clonazepam	Clonazepam	28	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	28	suppressed
Spironolactone	Spironolactone	27	suppressed
Ezetimibe	Ezetimibe	26	suppressed
Xarelto	Rivaroxaban	26	suppressed
Rexulti	Brexpiprazole	24	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	23	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	23	suppressed
Finasteride	Finasteride	23	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	23	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	22	suppressed
Azithromycin	Azithromycin	21	17
Clopidogrel	Clopidogrel Bisulfate	21	suppressed
Methocarbamol	Methocarbamol	21	suppressed
Naproxen	Naproxen	21	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	21	suppressed
Diazepam	Diazepam	20	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	20	18
Valsartan	Valsartan	20	suppressed
Fluconazole	Fluconazole	19	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	19	suppressed
Olanzapine	Olanzapine	19	suppressed
Torsemide	Torsemide	19	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	19	suppressed
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Lamotrigine	Lamotrigine	18	suppressed
Symbicort	Budesonide/Formoterol Fumarate	18	11
Advair Hfa	Fluticasone Propion/Salmeterol	17	suppressed
Ketoconazole	Ketoconazole	17	suppressed
Novolog Flexpen	Insulin Aspart	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Warfarin Sodium	Warfarin Sodium	17	suppressed
Atomoxetine Hcl	Atomoxetine Hcl	16	suppressed
Donepezil Hcl	Donepezil Hcl	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Vyvanse	Lisdexamfetamine Dimesylate	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Pravastatin Sodium	Pravastatin Sodium	15	suppressed
Vilazodone Hcl	Vilazodone Hcl	15	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	13
Celecoxib	Celecoxib	13	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	13	suppressed
Invokana	Canagliflozin	13	suppressed
Linzess	Linaclotide	13	suppressed
Rybelsus	Semaglutide	13	suppressed
Zonisamide	Zonisamide	13	suppressed
Alcohol Swabs	Alcohol Antiseptic Pads	12	suppressed
Cefdinir	Cefdinir	12	suppressed
Clonidine	Clonidine	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Methylprednisolone	Methylprednisolone	12	11
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	12
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Abilify Maintena	Aripiprazole	11	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Estradiol	Estradiol	11	suppressed
Midodrine Hcl	Midodrine Hcl	11	suppressed
Naltrexone Hcl	Naltrexone Hcl	11	suppressed
Ropinirole Hcl	Ropinirole Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error